Product Name | MF | CAS | Details |
---|
Ritonavir | C37H48N6O5S2 | 155213-67-5 | Details |
Diethyl ketomalonate | C7H10O5 | 609-09-6 | Details |
1Alpha-Methylandrosterone | C20H32O2 | 3398-67-2 | Details |
Methyltetrazine-PEG4-acid | C20H28N4O7 | 1802907-91-0 | Details |
Tolperisone | C16H23NO | 728-88-1 | Details |
3'-Amino-5'-O-p-anisoyl-3'-deoxythymidine | C18H21N3O6 | Details |
3-[(4-Aminophenyl)amino]propanamide hydrochloride | C9H14ClN3O | 1258650-10-0 | Details |
4-(Pyridin-4-yl)-4,5-dihydro-1H-1,2,4-triazol-5-one | C7H6N4O | 155431-59-7 | Details |
OR8G5 antibody | Details |
2-Methyl-3-(thiomorpholine-4-carbonyl)aniline | C12H16N2OS | 1042798-15-1 | Details |
Ethyl linoleate (U-13C18 ) | 202114-63-4 | Details |
2-Chloro-N-[2-(1H-indol-3-yl)ethyl]acetamide | C12H13ClN2O | 52191-26-1 | Details |
2-Chloro-N-[4-(morpholin-4-ylsulfonyl)phenyl]propanamide | C13H17ClN2O4S | 743444-65-7 | Details |
1,3-Dimethyl-5-iodopyrazole | C5H7IN2 | 85779-98-2 | Details |
5-Iodo-3-(trifluoromethyl)-1H-pyrazole | C4H2F3IN2 | 1015780-53-6 | Details |
1-(5-Bromopyridin-2-yl)cyclobutanamine | C9H11BrN2 | 1256793-73-3 | Details |
4,4'-Dinitro diphenyl disulfide | C12H8N2O4S2 | 100-32-3 | Details |
Hexasaccharide dp6 | Details |
N-(2-Aminoethyl)-6-chloropyrazin-2-amine | C6H9ClN4 | 1138220-48-0 | Details |
Fetuin A antibody | Details |
4-{[(tert-Butoxy)carbonyl]amino}-2,2-dimethyloxane-4-carboxylic acid | C13H23NO5 | 1404840-07-8 | Details |
Benzofuroxan | C6H4N2O2 | 480-96-6 | Details |
4-Cyanobenzaldehyde | C8H5NO | 105-07-7 | Details |
Methyl 2,4-dihydroxybenzoate | C8H8O4 | 2150-47-2 | Details |
3-(2-{[3-Methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}pyridin-4-yl)benzonitrile | C24H25N5O | 1417795-19-7 | Details |
VPS4B protein (His tag) | Details |
tert-Butyl 5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3,4,7-tetrahydro-1H-azepine-1-carboxylate | C17H30BNO4 | 951259-25-9 | Details |
2-Amino-N-(4-hydroxyphenyl)acetamide hydrochloride | C8H11ClN2O2 | 105396-69-8 | Details |
Alpha endosulfine antibody | Details |
Transferrin protein (FITC) | Details |
ZNF582 antibody | Details |
[5-(4-Methoxyphenyl)-1H-1,2,4-triazol-3-yl]methanamine hydrochloride | C10H13ClN4O | 1258650-54-2 | Details |
N6-Benzoyl-5'-O-DMT-2'-O-[([triisopropylsilyl]oxy])methyl]-adenosine | C48H57N5O8Si | 220230-55-7 | Details |
5-Amino-2,4-bis(trifluoromethyl)pentanoic acid hydrochloride | C7H10ClF6NO2 | 2260936-35-2 | Details |
HSPBAP1 Blocking Peptide | Details |
H-RLLPLLALL-OH | Details |
Methyl 3-(dimethylamino)pyrrolidine-1-carboxylate hydrochloride | 2377034-51-8 | Details |
1-(5-Ethylfuran-2-yl)ethan-1-one | C8H10O2 | 24119-98-0 | Details |
1-[(tert-butoxy)carbonyl]-4-methylpiperidine-2-carboxylic acid, Mixture of diastereomers | C12H21NO4 | 1262408-54-7 | Details |
Ciraparantag | C22H48N12O2 | 1438492-26-2 | Details |
3,6-Dibromo-2-fluoropyridine | C5H2Br2FN | 1256820-70-8 | Details |
3-(prop-2-yn-1-yl)oxazolidin-2-one | C6H7NO2 | 823-53-0 | Details |
2-hydroxy-5-phenylpentanoic acid | C11H14O3 | 104216-93-5 | Details |
5-Hydroxyquinolin-2(1H)-one | C9H7NO2 | 31570-97-5 | Details |
4-(azetidin-3-yloxy)benzonitrile hcl | C10H11ClN2O | 1236862-00-2 | Details |
2-(3,5-Dimethylphenoxy)-N-methylethanamine | C11H17NO | 875159-76-5 | Details |
2-Cyclobutoxybenzoic acid | C11H12O3 | 1275723-72-2 | Details |
2-Tridecyloxirane | C15H30O | 18633-25-5 | Details |
Cyclosporin AM 4N | C61H109N11O12 | 89270-23-5 | Details |
methyl 3-(2-thienylcarbonylamino)thiophene-2-carboxylate | C11H9NO3S2 | 545351-07-3 | Details |
4-(2-Fluoropropan-2-yl)piperidine hydrochloride | C8H16FN.ClH | 1896341-44-8 | Details |
5-Fluoropyridine-3-sulfonamide | C5H5FN2O2S | 1247591-65-6 | Details |
2'-Deoxy-5'-O-DMT-5-fluoro-O4-(2,4,6-trimethylphenyl)uridine 3'-CE phosphoramidite | C48H56FN4O8P | 198080-36-3 | Details |
3-(Oxolan-3-ylmethoxy)propan-1-amine | C8H17NO2 | 933701-26-9 | Details |
3-Chloro-N-[3-(pyrrolidine-1-sulfonyl)phenyl]propanamide | C13H17ClN2O3S | 950114-64-4 | Details |
3'-Azido-N4-benzoyl-5'-O-tert-butyldimethylsilyl-2',3'-dideoxycytidine | C22H30N6O4Si | 500701-38-2 | Details |
H-KLDLSNVQSK^-OH | Details |
H-Arg(Pmc)-2-chlorotrityl resin (200-400 mesh) | Details |
KYT-36 | C34H42N6O6 | 454473-31-5 | Details |
SKF 83959 | C18Cl1H20N1O2 | 67287-95-0 | Details |
1-({[(9H-Fluoren-9-yl)methoxy]carbonyl}(methyl)amino)cyclohexane-1-carboxylic acid | C23H25NO4 | 1697377-42-6 | Details |
3-(2,5-Difluorophenyl)propanoic acid | C9H8F2O2 | 130408-15-0 | Details |
2-Ethyl-3-[4-[(E)-3-(4-isopropylpiperazin-1-yl)propenyl]benzyl]-5,7-dimethyl-3H-imidazo[4,5-b]pyridine | C27H37N5 | 1197879-16-5 | Details |
3-Chloro-4-ethoxybenzonitrile | C9H8ClNO | 916596-02-6 | Details |
2'-Deoxy-5'-O-DMT-5-methylcytidine | C31H33N3O6 | 176755-83-2 | Details |
2-Methyl-3-(methylamino)propanoic acid hydrochloride | C5H12ClNO2 | 1240529-48-9 | Details |
1-(1-Phenylethyl)-1H-1,3-benzodiazol-2-amine | C15H15N3 | 63261-04-1 | Details |
3-(2-Cyclohexylethyl)pyridin-4-amine hydrochloride | C13H21ClN2 | 1375977-94-8 | Details |
3,5,3'-Trihydroxybibenzyl | C14H14O3 | 86630-23-1 | Details |
3-[5-(Methoxymethyl)-1,3,4-oxadiazol-2-yl]benzoic acid | C11H10N2O4 | 1432678-74-4 | Details |
1-[(tert-Butoxy)carbonyl]-3-({[(9H-fluoren-9-yl)methoxy]carbonyl}(methyl)amino)azetidine-3-carboxylic acid | C25H28N2O6 | 2137775-85-8 | Details |
UCHL1 (20-27) Heavy | Details |
Vitexin-2-O-rhamnoside | C27H30O14 | 64820-99-1 | Details |
Dabigatran impurity E | C20H22N4O3 | 1456889-80-7 | Details |
trans-2,5-Dichlorocinnamic acid | C9H6Cl2O2 | 20595-47-5 | Details |
5-(N-Methyl-N-trifluoromethylacetyl)aminomethyluridine | C13H16F3N3O7 | 163496-07-9 | Details |
2-(((5-methylisoxazol-3-yl)amino)ethylidene)indane-1,3-dione | C15H12N2O3 | 1023586-25-5 | Details |
MGC4172 antibody | Details |
H-IGMEVTPSGTWLTYTGAIK-OH | Details |
H-VLDVGDAYFSV-OH | Details |
5,7-Dichloro-1,2,3,4-tetrahydroisoquinoline hydrochloride | C9H10Cl3N | 73075-47-5 | Details |
3-(2-Bromophenyl)cyclobutan-1-one | C10H9BrO | 918299-24-8 | Details |
N-?(dimethyloxido-?λ4-?sulfanylidene)?-2-?Pyrrolidinecarboxami?de hydrochloride | C7H15ClN2O2S | 1955474-45-9 | Details |
BRD4 antibody | Details |
[1-(2-Methoxyethyl)cyclopropyl]methanamine | C7H15NO | 1421603-95-3 | Details |
Tilvestamab | 2226775-26-2 | Details |
5-(Dimethylsulfamoyl)-2-(piperidin-1-yl)benzoic acid | C14H20N2O4S | 77266-65-0 | Details |
DNAPK antibody (Thr2638) | Details |
1-(3-Chloropropyl)-2-methyl-1H-imidazole hydrochloride | C7H12Cl2N2 | 1421601-58-2 | Details |
COL16A1 antibody | Details |
4-(2-Chloroacetamido)butanoic acid | C6H10ClNO3 | 649556-05-8 | Details |
4-Trifluoromethanesulfinylbenzoic acid | C8H5F3O3S | 948-39-0 | Details |
5-Methyl-5-[4-(1H-1,2,3,4-tetrazol-1-yl)phenyl]imidazolidine-2,4-dione | C11H10N6O2 | 1240526-07-1 | Details |
Slc6a9 antibody | Details |
9H-Fluoren-9-ylmethyl 4-(2-hydroxyethyl)piperazine-1-carboxylate | C21H24N2O3 | 1342378-36-2 | Details |
Dynamin inhibitory peptide | C47H80N18O14 | 251634-21-6 | Details |
5'-O-DMT-2,3'-anhydrothymidine | C31H30N2O6 | 191474-13-2 | Details |
2-Hydroxy-2-methylbutane-1,4-dioic acid | C5H8O5 | 597-44-4 | Details |
4-Methoxy-N,N-dimethyl-3-sulfamoylbenzamide | C10H14N2O4S | 1479683-22-1 | Details |
Product Total: Product Page: | ||||
264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 |